Recent Articles from Investor's Business Daily
Reports suggest Novo Nordisk has asked the FDA to approve its oral semaglutide, two years after reporting a Phase 3 win.
Via Investor's Business Daily · April 22, 2025
IBM stock was gaining in trades ahead of its Q1 report. Some analysts expect the tech giant's shares will be seen as a "safe haven."
Via Investor's Business Daily · April 22, 2025
Wall Street analysts doled out mixed ratings on AI cloud computing services provider CoreWeave stock after its IPO. CoreWeave rents out Nvidia chip-equipped servers.
Via Investor's Business Daily · April 22, 2025
The company's bookings missed expectations for the fifth consecutive quarter. Investors are questioning its "path forward."
Via Investor's Business Daily · April 22, 2025
Elon Musk's departure from DOGE may brighten the outlook for government and military IT contractors such as Booz Allen Hamilton, William Blair says.
Via Investor's Business Daily · April 22, 2025
3M outlined how Trump's trade war could impact full-year profit on Tuesday.
Via Investor's Business Daily · April 22, 2025
The company's commentary on tariffs was a "pleasant surprise," according to one analyst.
Via Investor's Business Daily · April 22, 2025
Crypto stocks climb as bitcoin powers above $89,000 for the first time since early March. Strategy buys more bitcoin.
Via Investor's Business Daily · April 22, 2025
The company topped first-quarter expectations on strong requisition volume, and reaffirmed its outlook for the year.
Via Investor's Business Daily · April 22, 2025
The EV giant reports Q1 earnings after the close. All eyes are on Elon Musk.
Via Investor's Business Daily · April 22, 2025
The Dow giant topped Q1 earnings and revenue views.
Via Investor's Business Daily · April 22, 2025
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly.
Via Investor's Business Daily · April 21, 2025
Uber stock was lower as the FTC sued the ride-hail company for alleged deceptive practice for its Uber One subscription product.
Via Investor's Business Daily · April 21, 2025
Upstart Holdings stock had its Relative Strength (RS) Rating upgraded to 86 on Monday, up from 75 a day earlier.
Via Investor's Business Daily · April 21, 2025
While investors laid a smackdown on the major indexes Monday, Netflix stock flirted with a buy point from a double-bottom base.
Via Investor's Business Daily · April 21, 2025
Two Wall Street analysts clashed on the outlook for Salesforce stock amid the software maker's push into artificial intelligence products.
Via Investor's Business Daily · April 21, 2025
Software maker Palantir Technologies has won a new $30 million contract from the U.S. Immigration and Customs Enforcement, according to federal filings.
Via Investor's Business Daily · April 21, 2025
GE Aerospace reports Q1 results Tuesday. Analysts expect some near-term tariff and costs pressures to weigh on results.
Via Investor's Business Daily · April 21, 2025
China’s Huawei stepped up to fill the void in AI chips after the U.S. blocked Nvidia from selling to Chinese customers. Nvidia stock fell.
Via Investor's Business Daily · April 21, 2025
Gold and bitcoin are rallying as foreign investors shun U.S. financial assets.
Via Investor's Business Daily · April 21, 2025
Amazon stock was dropped as analysts drop strong buy pick because tariffs will likely pose greater threat to earnings than investors expect.
Via Investor's Business Daily · April 21, 2025
The company is getting a new chief executive and a new chief financial officer amid sweeping changes.
Via Investor's Business Daily · April 21, 2025
Morgan Stanley recently upgraded Lockheed Martin and hiked its Northrop price target.
Via Investor's Business Daily · April 21, 2025
Analysts are looking for answers on the Tesla earnings call late Tuesday.
Via Investor's Business Daily · April 21, 2025
Read inspirational quotes about setting goals, living for now and being happy with what you already have or can do.
Via Investor's Business Daily · April 21, 2025
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. On Monday, Smithfield Foods hit that mark.
Via Investor's Business Daily · April 21, 2025
Palantir and four other stocks near buy points are worth adding to watchlists.
Via Investor's Business Daily · April 19, 2025
Tesla reports first-quarter earnings and revenue late on Tuesday.
Via Investor's Business Daily · April 18, 2025
Nintendo announced Friday that it will keep the price of its upcoming Switch 2 video game console unchanged despite the Trump tariffs.
Via Investor's Business Daily · April 18, 2025
Netflix stock is set to break out from a double-bottom base on Monday if after-hours gains following its Q1 report carry over.
Via Investor's Business Daily · April 18, 2025
Fear often keeps people from taking the all-important first step towards success. You must learn to overcome fear.
Via Investor's Business Daily · April 18, 2025
Soaring gold prices have generated notable outperformance in 2025, but here's why traders shouldn't put all their eggs in one shiny basket.
Via Investor's Business Daily · April 17, 2025
Netflix beat Wall Street's targets for sales and earnings in Q1 and guided above views for the current period. Netflix stock rose.
Via Investor's Business Daily · April 17, 2025
One key metric to look for in a stock is an 80 or higher Relative Strength Rating. Maplebear stock hit that mark, with a jump to 83 Thursday.
Via Investor's Business Daily · April 17, 2025
Dollar General stock had its Relative Strength Rating upgraded to 78 Thursday — a nice improvement, but shy of the 80-plus preferred score.
Via Investor's Business Daily · April 17, 2025
HPE stock climbed amid a report activist investor Elliott Investment Management plans to seek the ouster of Chief Executive Antonio Neri.
Via Investor's Business Daily · April 17, 2025
Uber stock gained past a key level Thursday to close the week higher. Some analysts expect demand for ride-hailing would resist a recession.
Via Investor's Business Daily · April 17, 2025
The major indexes fell back from resistance at the 21-day moving average.
Via Investor's Business Daily · April 17, 2025
Meta stock analysts are debating what a pullback in ad spending from Temu and Shein could mean for Meta stock.
Via Investor's Business Daily · April 17, 2025
A federal judge ruled that Alphabet has used classic monopoly-building tactics to dominate online advertising. Google stock fell amid the news.
Via Investor's Business Daily · April 17, 2025
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Via Investor's Business Daily · April 17, 2025
Charles Schwab stock surges, eyes rebound above key line near buy point on earnings. New assets, accounts, trading volume jump.
Via Investor's Business Daily · April 17, 2025
Investors will be watching for any tariff news coming out of Trump's meeting with Italian Prime Minister Giorgia Meloni.
Via Investor's Business Daily · April 17, 2025
Eli Lilly's pill-form weight loss drug cansdidate cleared one of several Phase III hurdles.
Via Investor's Business Daily · April 17, 2025
Hertz stock rallies after SEC filings show that Bill Ackman's Pershing Square has taken a large stake in the car rental company.
Via Investor's Business Daily · April 17, 2025
Crypto IPOs once counting on regulatory rollbacks and market enthusiasm had their plans dashed by turmoil. Why nobody now wants to go first.
Via Investor's Business Daily · April 17, 2025
Stephanie Kwolek was the unlikely DuPont chemist who invented Kevlar, the miracle fiber that's five times stronger than steel.
Via Investor's Business Daily · April 17, 2025
The Dow giant missed Q1 views and full-year 25 EPS targets on Medicare costs.
Via Investor's Business Daily · April 17, 2025
Taiwan Semiconductor Manufacturing beat estimates for the first quarter thanks to strong demand for AI chips. TSM stock rose.
Via Investor's Business Daily · April 17, 2025
On Wednesday, MakeMyTrip stock reached a key benchmark, with its Relative Strength Rating improvement to 91, up from 87 the day before.
Via Investor's Business Daily · April 16, 2025
One key metric to look for in a stock is an 80-plus Relative Strength Rating. Nutanix stock clears that threshold, jumping to 84 Wednesday.
Via Investor's Business Daily · April 16, 2025
Autodesk stock had its Relative Strength Rating upgraded to 74 Wednesday — a nice improvement, but shy of the 80-plus preferred score.
Via Investor's Business Daily · April 16, 2025
Software maker Salesforce disclosed that fiscal 2025 annual recurring revenue from its "Data Cloud" and artificial intelligence products reached $900 million.
Via Investor's Business Daily · April 16, 2025
The Fed chief hinted tariffs will be "challenging" for the central bank's dual mandate.
Via Investor's Business Daily · April 16, 2025
S&P 500 defense stocks Lockheed Martin and Northrop Grumman advanced Wednesday.
Via Investor's Business Daily · April 16, 2025
A Wall Street analyst who is bearish on Meta stock further cut his price target, saying the Facebook parent company looks vulnerable.
Via Investor's Business Daily · April 16, 2025
While analysts remain bullish overall on Amazon stock, several have cut their price targets for the tech giant ahead of its Q1 report.
Via Investor's Business Daily · April 16, 2025
The Trump administration has effectively barred Nvidia from selling its custom AI processors to customers in China. Nvidia stock fell.
Via Investor's Business Daily · April 16, 2025
Lyft stock gained on news the ride-hail company is expanding to Europe through a deal to buy taxi app FreeNow.
Via Investor's Business Daily · April 16, 2025
Abbott stock slipped early Wednesday after the health giant reported light first-quarter sales, though profit beat views.
Via Investor's Business Daily · April 16, 2025
Cybersecurity stocks are showing resilience amid a downturn in the technology sector.
Via Investor's Business Daily · April 16, 2025
Tesla stock declined early Wednesday after Reuters reported that Trump tariffs on China have made the EV giant pause component shipments.
Via Investor's Business Daily · April 16, 2025
Dow Jones insurer Travelers crushed Q1 earnings views early Wednesday despite sizable losses from the California wildfires.
Via Investor's Business Daily · April 16, 2025
March auto sales in particular were strong.
Via Investor's Business Daily · April 16, 2025
Semiconductor equipment maker ASML beat estimates for the first quarter but its Q2 sales guidance was short of views. ASML stock fell.
Via Investor's Business Daily · April 16, 2025

GeneDx will pay up to $84 million to acquire Fabric Genomics for its AI-powered genomics interpretation platform.
Via Investor's Business Daily · April 16, 2025
Netflix stock, ServiceTitan, Zscaler, AngloGold Ashanti, Virtu Financial and MakeMyTrip are the new stocks on IBD's proprietary watchlists.
Via Investor's Business Daily · April 15, 2025
The H20 is specifically designed for the China market to comply with export restrictions.
Via Investor's Business Daily · April 15, 2025
A Wall Street firm cut its price targets on Microsoft and 50 other software stocks on Tuesday, citing a weakening macroeconomic outlook.
Via Investor's Business Daily · April 15, 2025
Semiconductor plays exposed to the AI megatrend, such as Nvidia stock, are best positioned for Q1 earnings season, an analyst says.
Via Investor's Business Daily · April 15, 2025
HPE stock climbed amid a report activist investor Elliott Investment Management has taken a stake valued at over $1.5 billion in the company.
Via Investor's Business Daily · April 15, 2025
Rocket Lab shares jump after being selected for two, multi-billion contracts for hypersonic tech from the U.S. and U.K.
Via Investor's Business Daily · April 15, 2025
Johnson & Johnson stock fell alongside the broader market, despite beating first-quarter calls and hiking its sales outlook.
Via Investor's Business Daily · April 15, 2025
Boeing stock falls on reports that China will halt orders from the Dow Jones manufacturer in response to President Trump's tariffs.
Via Investor's Business Daily · April 15, 2025
The companies are facing off with their heart drugs in a growing disease area.
Via Investor's Business Daily · April 14, 2025